MX2024005656A - Inhibidores de proteina tirosina fosfatasa y metodos de uso de estos. - Google Patents
Inhibidores de proteina tirosina fosfatasa y metodos de uso de estos.Info
- Publication number
- MX2024005656A MX2024005656A MX2024005656A MX2024005656A MX2024005656A MX 2024005656 A MX2024005656 A MX 2024005656A MX 2024005656 A MX2024005656 A MX 2024005656A MX 2024005656 A MX2024005656 A MX 2024005656A MX 2024005656 A MX2024005656 A MX 2024005656A
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- protein tyrosine
- tyrosine phosphatase
- phosphatase inhibitors
- agents
- Prior art date
Links
- 239000003806 protein tyrosine phosphatase inhibitor Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 208000002154 non-small cell lung carcinoma Diseases 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/433—Thidiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163278336P | 2021-11-11 | 2021-11-11 | |
| PCT/US2022/049581 WO2023086495A1 (en) | 2021-11-11 | 2022-11-10 | Protein tyrosine phosphatase inhibitors and methods of use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2024005656A true MX2024005656A (es) | 2024-08-06 |
Family
ID=84887566
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2024005656A MX2024005656A (es) | 2021-11-11 | 2022-11-10 | Inhibidores de proteina tirosina fosfatasa y metodos de uso de estos. |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20250042894A1 (enExample) |
| EP (1) | EP4430039A1 (enExample) |
| JP (1) | JP2024543451A (enExample) |
| CN (1) | CN118556055A (enExample) |
| AU (1) | AU2022386164A1 (enExample) |
| CA (1) | CA3236853A1 (enExample) |
| MX (1) | MX2024005656A (enExample) |
| WO (1) | WO2023086495A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024243441A1 (en) | 2023-05-24 | 2024-11-28 | Kumquat Biosciences Inc. | Heterocyclic compounds and uses thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA94921C2 (en) * | 2005-12-08 | 2011-06-25 | Новартис Аг | 1-orthofluorophenyl substituted 1, 2, 5-thiazolidinedione derivatives as ptp-as inhibitors |
| TWI888352B (zh) * | 2018-06-21 | 2025-07-01 | 美商嘉來克生命科學有限責任公司 | 蛋白質酪胺酸磷酸酯酶抑制劑及其使用方法 |
| KR102983496B1 (ko) * | 2019-03-14 | 2026-06-29 | 칼리코 라이프 사이언시스 엘엘씨 | 단백질 티로신 포스파타제 억제제 및 이의 사용 방법 |
| MX2022007441A (es) * | 2019-12-18 | 2022-09-02 | Calico Life Sciences Llc | Inhibidores de proteína tirosina fosfatasa y sus métodos de uso. |
-
2022
- 2022-11-10 CN CN202280088452.2A patent/CN118556055A/zh active Pending
- 2022-11-10 WO PCT/US2022/049581 patent/WO2023086495A1/en not_active Ceased
- 2022-11-10 CA CA3236853A patent/CA3236853A1/en active Pending
- 2022-11-10 US US18/709,204 patent/US20250042894A1/en active Pending
- 2022-11-10 MX MX2024005656A patent/MX2024005656A/es unknown
- 2022-11-10 JP JP2024527749A patent/JP2024543451A/ja active Pending
- 2022-11-10 AU AU2022386164A patent/AU2022386164A1/en active Pending
- 2022-11-10 EP EP22839527.3A patent/EP4430039A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2022386164A1 (en) | 2024-05-23 |
| CN118556055A (zh) | 2024-08-27 |
| JP2024543451A (ja) | 2024-11-21 |
| EP4430039A1 (en) | 2024-09-18 |
| CA3236853A1 (en) | 2023-05-19 |
| US20250042894A1 (en) | 2025-02-06 |
| WO2023086495A1 (en) | 2023-05-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2022001158A (es) | Inhibidores dobles de atm y adn-pk para uso en terapias antitumorales. | |
| CL2021001722A1 (es) | Inhibidores aza-heterobicíclicos de mat2a y métodos de uso en el tratamiento de cáncer | |
| CL2020002405A1 (es) | Inhibidores de kras g12c y métodos para su uso (divisional de la solicitud no. 201903394) | |
| CL2021001721A1 (es) | Inhibidores aza-heterobicíclicos de mat2a y métodos de uso para tratar el cáncer | |
| CO2022008091A2 (es) | Inhibidores de kras g12c | |
| MX2020012261A (es) | Inhibidores de kras g12c que comprenden un anillo de piperazina y uso de estos en el tratamiento del cancer. | |
| JOP20200315A1 (ar) | مركبات بورينون واستخدامها في معالجة السرطان | |
| MX2021013662A (es) | Inhibidores de la autofagia de heteroarilaminopirimidina amida y metodos de uso de estos. | |
| MX2021011209A (es) | Novedosos inhibidores de molécula pequeña de factores de transcripción tead. | |
| MX2023008031A (es) | Inhibidores de la cinasa 2 de control general no desrepresible (gcn2) y usos de los mismos. | |
| JOP20190151B1 (ar) | مركبات أمينو - ترايازولو بيريدين واستخدامها في علاج سرطان | |
| MX2021014455A (es) | Inhibidores de proteina cinasas dependientes de adn. | |
| CO2022000481A2 (es) | Inhibidores de enzimas | |
| CL2023002362A1 (es) | Derivados de tetrahidroazepina bicíclicos para el tratamiento del cáncer | |
| CL2021003568A1 (es) | Compuestos heteroaromáticos como inhibidores de vanina (divisional de solicitud n° 202101198) | |
| MX2021002215A (es) | Derivados de tetrahidropiridopirimidina como moduladores de ahr. | |
| MX2024005658A (es) | Inhibidores de proteina tirosina fosfatasa y metodos de uso de estos. | |
| CO2020013834A2 (es) | Ciertos compuestos de pladienolida y métodos de uso | |
| CO2022000266A2 (es) | Inhibidores de enzimas | |
| MX2019003317A (es) | Metodo para tratar cancer usando una combinacion de agentes que dañan adn e inhibidores de proteina cinasa dependiente de adn (adn-pk). | |
| CY1124751T1 (el) | Συνδυαστικες αγωγες οι οποιες περιλαμβανουν χορηγηση 1η-πυραζολο[4,3-b]πυριδινων | |
| MX2021009426A (es) | Derivados de indazolil-isoxazol para el tratamiento de enfermedades tales como cancer. | |
| MX2022006308A (es) | Derivados de carbazol polimorfos y usos de los mismos. | |
| CL2025003313A1 (es) | Compuestos derivados de feniloxazolona sustituida. | |
| CO2025016192A2 (es) | Moléculas y métodos de uso de estas |